Trifluoroacetic acid → 4-[9-(Benzoylamino)-6,10-dioxo-1,2,3,4,7,8,9,10-octahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxamido]-5-oxopentanoic acid

HRID 363862노트

반응식

HRID 363862 반응식
[C:1]([NH:9][CH:10]1[C:16](=[O:17])[N:15]2[CH:18]([C:22]([NH:24][CH:25]([CH:35]=[O:36])[CH2:26][CH2:27][C:28]([O:30]C(C)(C)C)=[O:29])=[O:23])[CH2:19][CH2:20][CH2:21][N:14]2[C:13](=[O:37])[CH2:12][CH2:11]1)(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.FC(F)(F)C(O)=O>C(Cl)Cl>[C:1]([NH:9][CH:10]1[C:16](=[O:17])[N:15]2[CH:18]([C:22]([NH:24][CH:25]([CH:35]=[O:36])[CH2:26][CH2:27][C:28]([OH:30])=[O:29])=[O:23])[CH2:19][CH2:20][CH2:21][N:14]2[C:13](=[O:37])[CH2:12][CH2:11]1)(=[O:8])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

참가 물질

4

반응 조건

온도
0 °C

실험 절차

A solution of t-butyl ester 234e (179 mg, 0.35 mmol) in dry CH2Cl2 (3 ml) was cooled to 0° C. and treated with trifluoroacetic acid (2 ml). The resulting solution was stirred at 0° C. for 30 min and then at room temperature for 2 h. The solution was concentrated, the residue taken up in dry CH2Cl2 (5 ml) and the mixture again concentrated. This process was repeated once again with more CH2Cl2 (5 ml). The residue obtained was crystallized in diethyl ether. The precipitate was collected and purified on silica gel column (5% methanol in CH2Cl2) which afforded compound 235e as a white solid (111 mg, 70%): mp 142° C. (dec); [α]D20 -85.5° (c 0.062, MeOH); IR (KBr) 3409, 3075, 2952, 1651, 1541, 1424, 1280, 1198, 1136, 717; 1H NMR (D6 -DMSO) δ 9.40 (1H, s), 8.62 (2H, m), 7.96-7.38 (5H, m), 5.19-5.02 (1H, m), 4.98-4.79 (1H, m), 4.48-4.19 (1H, m), 3.51-3.11 (2H, m), 3.04-2.90 (2H, m), 2.38-1.46 (10H, m).

후처리

  1. waitat room temperature for 2 h
  2. concentrationThe solution was concentrated
  3. concentrationthe mixture again concentrated
  4. customThe residue obtained
  5. customwas crystallized in diethyl ether
  6. customThe precipitate was collected
  7. custompurified on silica gel column (5% methanol in CH2Cl2) which

출처 및 근거

ORD 기록
ord-949f276d5bae47629fbd8372c1407c9a
출처 데이터셋
uspto-grants-1999_02
특허 번호
US05874424

반응 노트

불러오는 중…